Cargando…
Venetoclax imparts distinct cell death sensitivity and adaptivity patterns in T cells
BH3 mimetics are increasingly used as anti-cancer therapeutics either alone or in conjunction with other chemotherapies. However, mounting evidence has also demonstrated that BH3 mimetics modulate varied amounts of apoptotic signaling in healthy immune populations. In order to maximize their clinica...
Autores principales: | Ludwig, Lindsey M., Hawley, Katrina M., Banks, David B., Thomas-Toth, Anika T., Blazar, Bruce R., McNerney, Megan E., Leverson, Joel D., LaBelle, James L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551340/ https://www.ncbi.nlm.nih.gov/pubmed/34707089 http://dx.doi.org/10.1038/s41419-021-04285-4 |
Ejemplares similares
-
Hematologic Tumor Cell Resistance to the BCL-2 Inhibitor Venetoclax: A Product of Its Microenvironment?
por: Leverson, Joel D., et al.
Publicado: (2018) -
Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation
por: Ludwig, Lindsey M., et al.
Publicado: (2016) -
Potential mechanisms of resistance to venetoclax and strategies to circumvent it
por: Tahir, Stephen K., et al.
Publicado: (2017) -
Inhibition of FOXP3 by stapled alpha-helical peptides dampens regulatory T cell function
por: Hawley, Katrina M., et al.
Publicado: (2022) -
Distinct Allelic Patterns of Nanog Expression Impart Embryonic Stem Cell Population Heterogeneity
por: Wu, Jincheng, et al.
Publicado: (2013)